Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

Buy Here: <a href=" The Seasonic Vertex GX-1200 Power Supply! Our Merch: <a href=" CONNECT WITH US! Facebook: <a href=" ...

Arc'teryx’s new footwear models will be available globally, launching throughout 2025. The Norvan LD 4 arrives in March, ...

the Vertex Speed draws inspiration from both trail runners and mountain climbing shoes. Featuring a zoned outsole built for a range of trails, the shoe is equipped with a shock-absorbing midsole ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

"We want to be the leader in pinnacle mountain terrain. Everything we do and create is around the mountain athlete and how these people move," Arc'teryx VP of footwear Ovidio Garcia told FN.

We are inching, it seems, towards a world of US$3000/oz gold, or we were at least before a dive on Thursday, with futures ...

Skyfall’s flooded timber, swampy oak thickets, 20-acre lake and adjacency to the Trinity River is as attractive to ducks as ...

We live in dangerous times, the security of Europe is seriously threatened, the question is now whether we will be ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...